◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Processa Pharmaceuticals, Inc.

CIK: 1533743 SIC: 2834
-
Revenue
$-13.56M
Net Income
-
Gross Margin
-
Op. Margin
$-19.12M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 37 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Operating Income $-3.70M $-3.49M $-3.95M $-2.85M $-2.73M $-3.42M $-3.08M
Interest Expense $18.00 $5.59K $1.88K $1.88K - - -
Interest Income - - - - $6.02K $40.15K -
Other Income/Expense - - - - - - $71.70K
Income Before Tax - - - - - - $-3.01M
Net Income $-3.36M $-3.44M $-3.93M $-2.83M $-2.73M $-3.38M $-3.01M
Basic EPS nan -0.07 -0.25 -0.30 nan -1.03 -1.01
Diluted EPS nan -0.07 -0.25 -0.30 nan -1.03 -1.01
Basic Shares Outstanding - 47.5M 15.6M 9.5M - 3.3M 3.0M
Diluted Shares Outstanding - 47.5M 15.6M 9.5M - 3.3M 3.0M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $5.54M $6.31M $6.94M $2.90M $1.19M $2.89M $5.57M
Other Current Assets $133.92K $278.34K $217.20K $860.81K $687.83K $1.95M $1.91M
Total Current Assets $5.67M $6.59M $7.15M $3.76M $1.88M $4.84M $7.48M
Property Plant & Equipment $3.81K $4.11K - - $5.02K $5.32K $2.28K
Total Assets $7.81M $7.58M $8.18M $4.81M $3.23M $4.94M $7.60M
Accounts Payable $1.06M $727.17K $785.75K $552.56K $880.88K $711.71K $953.09K
Accrued Liabilities $1.18M $1.02M $1.26M $680.75K $578.73K $412.81K $505.40K
Total Current Liabilities $2.24M $1.75M $2.07M $1.28M $1.53M $1.22M $1.55M
Total Liabilities $2.24M $1.75M $2.07M $1.28M $1.53M $1.22M $1.58M
Common Stock $257.00 $5.29K $4.03K $527.00 $15.00 $327.00 $287.00
Retained Earnings $-100.78M $-97.42M $-93.99M $-90.05M $-87.22M $-84.49M $-81.11M
Treasury Stock $300.00K $300.00K $300.00K $300.00K $300.00K $300.00K $300.00K
Total Stockholders Equity $5.58M $5.83M $6.11M $3.53M $1.70M $3.72M $6.02M
Total Liabilities & Equity $7.81M $7.58M $8.18M $4.81M $3.23M $4.94M $7.60M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-3.36M $-3.44M $-3.93M $-2.83M $-2.73M $-3.38M $-3.01M
Stock-based Compensation $123.54K $734.01K $430.96K $227.71K $155.05K $154.19K $320.27K
Change in Payables $329.62K $-153.71K $-95.13K $-328.32K $169.17K $400.09K $641.47K
Operating Cash Flow $-2.90M $-8.48M $-5.00M $-2.73M $-2.25M $-9.00M $-5.39M
Capital Expenditure - - - - - $3.24K -
Investing Cash Flow - - - - - $-3.24K -
Stock Issued - - - $4.44M $549.36K $7.21M $6.28M
Financing Cash Flow $2.98M $13.60M $10.75M $4.44M $547.58K $7.19M $6.26M
Net Change in Cash $-771.47K $5.12M $5.75M $1.71M $-1.70M $-1.81M $864.92K
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Income $-3.49M - $-10.29M -
Interest Expense - - $5.59K -
Net Income $-3.44M $-3.01M $-10.20M -
Basic EPS -0.07 - -0.41 -
Diluted EPS -0.07 - -0.41 -
Basic Shares Outstanding $47.53M - $24.84M -
Diluted Shares Outstanding $47.53M - $24.84M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $6.31M $1.19M
Other Current Assets $278.34K $687.83K
Total Current Assets $6.59M $1.88M
Property Plant & Equipment $4.11K $5.02K
Total Assets $7.58M $3.23M
Accounts Payable $727.17K $880.88K
Accrued Liabilities $1.02M $578.73K
Total Current Liabilities $1.75M $1.53M
Total Liabilities $1.75M $1.53M
Common Stock $5.29K $371.00
Retained Earnings $-97.42M $-87.22M
Treasury Stock $300.00K $300.00K
Total Stockholders Equity $5.83M $1.70M
Total Liabilities & Equity $7.58M $3.23M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-3.44M $-3.01M $-10.20M -
Stock-based Compensation - - $734.01K -
Change in Payables - - $-153.71K -
Operating Cash Flow - - $-8.48M -
Investing Cash Flow - - - -
Financing Cash Flow - - $13.60M -
Net Change in Cash - - $5.12M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...